Melatonin has potential to reduce risk of age-related macular degeneration
Researchers examined data of more than 200,000 people, 121,523 of which had no history of AMD.
Bausch + Lomb launches new INFUSE for Astigmatism contact lenses in the US
The silicone hydrogel daily disposable lenses contain a blend of osmoprotectants, electrolytes, and moisturizers to provide stable vision and keep eyes comfortable for 16 hours.
Get in the groove at AOA and AOSA's Optometry's Meeting 2024
Harmonize your vision in Nashville.
Zenni Optical now offering contact lenses
The company currently has CooperVision and Bausch + Lomb contact lenses available for customers to order.
More than a flag: Improving LGBTQ patient care through education, training, and access
LGBTQ patients are more at risk for not receiving health care due to fear of discrimination.
Researchers identify risk factors for retinal detachment in Marfan syndrome after pediatric lens removal
The French study found that a complete capsular removal seemed to be the safer option for pediatric patients with Marfan syndrome in terms of risk of retinal detachment.
What happened in optometry this week: June 3 - June 7
Catch up on what happened in optometry during the week of June 3-June 7.
BioTissue unveils new cryopreserved amniotic membrane solution for patients with ocular surface diseases
The solution, CAM360 AmnioGraft, is hydrated and shelf-stable without need for refrigeration.
NORA opens up nominations for several awards in neuro-optometric rehabilitation
Award winners will be announced at the NORA 2024 Conference from September 19-22 in Kissimmee, Florida.
Azura Ophthalmics enrolls first patient in Phase 3 clinical trial for AZR-MD-001 in patients with MGD
The trial, in part of the ASTRO study, will evaluate the efficacy, safety, and tolerability of sterile ophthalmic ointment 0.5%.
WCO, Alcon continue partnership with updates to educational resources
One of the resources provided by the partnership is a Dry Eye Wheel, which provides mitigation, measurement, and management processes to inform the treatment of dry eye disease.
Harrow announces data at week 52 from ESSENCE-2 open-label extension study
The study demonstrated sustained safety and efficacy of cyclosporine ophthalmic solution (Vevye) 0.1%, with many patients now entering their sixth refill cycle, according to the company.
Study finds extended benefits when treating TED patients with TEPEZZA
The high-level analysis found in treatment follow-up that 82% of patients administered with TEPEZZA did not report needing any additional thyroid eye disease treatment for nearly 2 years.
LambdaVision announces first closing of seed round for preclinical artificial retina trials
The biotechnology company is developing the first protein-based artificial retina for patients with retinitis pigmentosa and age-related macular degeneration.
Nordic Pharma announces commercial launch of Lacrifill canalicular gel
The novel therapy for dry eye is a cross-linked hyaluronic acid derivative cleared by the FDA.
Bausch + Lomb announces Blink NutriTears launch in the US
The launch of the nutritional supplement follows a clinical trial that demonstrated healthy tear production and provided noticeable relief of dry eye symptoms in as little as 2 to 4 weeks.
New handheld pachymeter launched by Lumibird division
The pachymeter is the most lightweight handheld product of its kind on the market, according to the company.
What happened in optometry this week: May 27 - May 31
Catch up on what happened in optometry during the week of May 27-May 31.
UnitedHealthcare Vision takes on myopia awareness initiatives
The company’s initiatives include involvement with the Global Myopia Awareness Coalition and discounting blue light screen protectors and its pediatric eye care program, among others.
DryEye Rescue to become US's sole distributor of InflammaDry Dry Eye Test
InflammaDry is a diagnostic test that detects elevated levels of MMP-9, an inflammatory marker consistently found in the tears of patients with DED.